Whitehawk Therapeutics, Inc. (WHWK) — Cash Flow Quality Index
Latest as of March 2025:
-0.16x
Whitehawk Therapeutics, Inc. (WHWK) has a Cash Flow Quality Index of -0.16x as of March 2025. Operating cash flow of $-11.86 Million is below net income of $73.02 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Whitehawk Therapeutics, Inc. total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
-0.16x
Operating CF / Net Income
Operating Cash Flow
$-11.86 Million
USD
Net Income
$73.02 Million
USD
Data as of
Mar 2025
Most recent filing
Annual Cash Flow Quality Index for Whitehawk Therapeutics, Inc. (None–None)
Year-by-year earnings quality comparison for Whitehawk Therapeutics, Inc.. For live market cap and the full company financial profile, see Whitehawk Therapeutics, Inc. (WHWK) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.